
Bone Modifying Agents
Two Onc Docs
00:00
Introduction
Exploring the role of Bisphosphonates and Denosumab in reducing skeletal related events in cancer patients with bone metastases, emphasizing their importance for healthcare professionals in oncology and internal medicine.
Transcript
Play full episode